Minimal Residual Disease (MRD) Testing News and reporting on minimal residual disease testing. Foundation Medicine Monitoring Assays Show Promise for Guiding Lung Cancer Chemo-Immunotherapy Premium Investigators showed that patients who are positive for ctDNA at the time of their fourth induction treatment have poorer outcomes and could benefit from new strategies. Invitae Publishes First Validation Data on MRD Assays, Laying Path to Future Clinical Expansion Premium The analytical validity study is the first published featuring full performance data for the firm's Personalized Cancer Monitoring technology. Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy Researchers came up with a single-cell DNA sequencing and immunophenotyping assay for identifying and characterizing AML clones that persist after treatment. Myriad Genetics, Memorial Sloan Kettering Partner to Study MRD Testing in Breast Cancer The collaborators will evaluate the use of Myriad's MRD platform in predicting response to CDK4/6 inhibitors and in a chemotherapy neoadjuvant setting. Natera Raises Full-Year Revenue Guidance on Test Volume Growth, Rosy Reimbursement Outlook Premium The company realized Q2 revenues from a recent surge in carrier testing volumes and expressed confidence in the potential inclusion of MRD testing in NCCN guidelines. Aug 2, 2023 Exact Sciences Details Late-Year MRD Testing Plans, Highlights Cologuard Growth Premium Jul 31, 2023 Natera Sues NeoGenomics for Patent Infringement Jul 27, 2023 NeoGenomics Gets Medicare Coverage for Radar Minimal Residual Disease Assay in Breast Cancer Jul 20, 2023 Guardant Health MRD Test Garners Coverage From Blue Cross, Blue Shield of Louisiana Jun 27, 2023 Personalis Sues Foresight Diagnostics Again Alleging Patent Infringement Jun 21, 2023 Exact Sciences Releases Next-Gen Cologuard Data, Inks New Partnerships Jun 15, 2023 Liquid Biopsy Firms Eye Melanoma for Minimal Residual Disease Testing, Though Questions Remain Premium Jun 12, 2023 Myriad Genetics, MD Anderson Partner to Study MRD Testing in Renal Cell Carcinoma Jun 6, 2023 Personalized Residual Disease Assays Show Promise to Overcome Liquid Biopsy Challenges in Sarcomas Premium Jun 2, 2023 Invivoscribe, Complete Genomics Partner to Develop, Commercialize Oncology Biomarker Tests May 16, 2023 Personalis, Ono Pharmaceutical, Japan National Cancer Center Partner on Opdivo Rectal Cancer Trial May 15, 2023 Jury Awards Natera $19.4M in Damages in Invitae, ArcherDx Patent Infringement Suit May 9, 2023 NeoGenomics Turnaround Takes Hold as Firm Begins Clinical Push for Radar MRD Test Premium May 3, 2023 Adela Ramps up Data Development for Epigenetic Multi-Cancer Detection, MRD Applications Premium May 2, 2023 Personalis to Test MRD Assay in Triple-Negative Breast Cancer Trial With ABRCC, Criterium Apr 27, 2023 Quest Diagnostics to Acquire Liquid Biopsy Firm Haystack Oncology for up to $450M Apr 27, 2023 Foresight Diagnostics Closes $58.8M Series B Round Apr 27, 2023 Quest Adds to Cancer Portfolio With $450M Buy of Haystack Oncology; Q1 Revenues Down 11 Percent Premium Apr 20, 2023 C2i Genomics Expands Data on Whole-Genome Sequencing MRD Test in Colon, Lung Cancer Premium Apr 11, 2023 Fulgent Genetics, Mission Bio Partner to Offer Single-Cell Assays Load More Breaking News Genetic Contributors to Plasma Protein Levels Unearthed in Multiple Studies Standard BioTools, SomaLogic to Merge Arima Genomics, Protean BioDiagnostics Launch 3D Genomics Cancer Testing Joint Venture Pathnostics UTI Test Nabs New York State Approval NanoString, A*Star, Next Level Genomics to Launch Spatial Biology Laboratory in Singapore The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.